Lorena Lôbo de Figueiredo-Pontes

DNMT1-interacting RNAs block gene-specific DNA methylation

Annalisa Di Ruscio, Alexander K. Ebralidze, Touati Benoukraf et al. · Nature · 2013 · 511 citations · Full text

Preclinical Rationale for Use of the Clinically Available Multitargeted Tyrosine Kinase Inhibitor Crizotinib in ROS1-Translocated Lung Cancer

Hiroyuki Yasuda, Lorena Lôbo de Figueiredo-Pontes, Susumu Kobayashi et al. · Journal of Thoracic Oncology · 2012 · 164 citations · Full text

Oncology, Medicine, Bronchial Neoplasm +7

Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells

Robert S. Welner, Giovanni Amabile, Deepak Bararia et al. · Cancer Cell · 2015 · 130 citations · Full text

Progenitor Cells, Hematological Malignancy, Medicine +14

Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer

Norihiro Yamaguchi, Antonio R. Lucena‐Araujo, Sohei Nakayama et al. · Lung Cancer · 2013 · 93 citations · Full text

Radiation Oncology, Egfr Inhibition, Medicine +6

Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)

Daniel da Rocha Lucena, J.A. Ribeiro, Rogério A. Costa et al. · British Journal of Ophthalmology · 2009 · 86 citations